Critical Care

official impact factor 4.60

Open Access Highly Access Research

Importance of nondrug costs of intravenous antibiotic therapy

Arthur RH van Zanten*, Peter M Engelfriet, Karin van Dillen, Miriam van Veen, Mark JC Nuijten and Kees H Polderman

Critical Care 2003, 7:R184-R190 doi:10.1186/cc2388


See related Commentary: http://ccforum.com/content/7/6/420

No comments have yet been made on this article.

Post a comment